BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2025 1:05:43 PM | Browse: 22 | Download: 34
 |
Received |
|
2024-12-09 07:01 |
|
Peer-Review Started |
|
2024-12-11 01:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-01-12 09:02 |
|
Revised |
|
2025-01-22 03:39 |
|
Second Decision |
|
2025-02-08 02:32 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-02-08 10:58 |
|
Articles in Press |
|
2025-02-08 10:58 |
|
Publication Fee Transferred |
|
2025-01-28 20:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-04-03 00:51 |
|
Publish the Manuscript Online |
|
2025-04-09 13:05 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Survival and treatment of stage IV renal cell carcinoma in academic vs non-academic medical centers
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bob Weng, Marco Braaten, Jenna Lehn, Reid Morrissey, Muhammad Sohaib Asghar, Peter Silberstein, Ali Bin Abdul Jabbar, Abraham Mathews, Abubakar Tauseef and Mohsin Mirza |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bob Weng, Department of Internal Medicine, Creighton University School of Medicine, CL and Rachel Werner Center for Health Sciences Education 2616 Burt Street, Omaha, NE 68178, United States. bobweng@creighton.edu |
| Key Words |
Renal cell carcinoma; Academic; Non-academic; Facility; Center; Type; Survival; Outcome |
| Core Tip |
Treatment of renal cell carcinoma (RCC) has been historically challenging. Our objective is to explore the contextual factors influencing RCC patients and their outcomes, primarily between those receiving care at academic compared to non-academic institutions. Previous studies on other cancers have some but limited insight into the remarkable discrepancy in survival in favor of academic centers. We aim to elucidate these findings for RCC using the National Cancer Database which unprecedentedly now enables analyzing large numbers of patients across long spans of time. |
| Publish Date |
2025-04-09 13:05 |
| Citation |
<p>Weng B, Braaten M, Lehn J, Morrissey R, Asghar MS, Silberstein P, Abdul Jabbar AB, Mathews A, Tauseef A, Mirza M. Survival and treatment of stage IV renal cell carcinoma in academic vs non-academic medical centers. <i>World J Nephrol</i> 2025; 14(2): 103923</p> |
| URL |
https://www.wjgnet.com/2220-6124/full/v14/i2/103923.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v14.i2.103923 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
